Moreover, adoptive transfer of FAP-targeted chimeric antigen receptor (CAR) T cells could specifically kill FAP+ CAFs and induce multiple beneficial stroma alterations, leading to delayed tumor growth and survival extension in mouse models of NSCLC and PDAC (93, 94). This evidence concerns the gene FAP and non-small cell lung carcinoma.